What is ETHZilla Corporation Warrant (ATNFW)?

ETHZilla Corporation Warrant (ATNFW) is a stock in the Healthcare sector, Medical - Pharmaceuticals industry. View full analysis on Stocks360.

What is the current price of ATNFW?

The current price of ATNFW is $0.43. Prices are updated in real time on Stocks360.

What is ATNFW's price-to-earnings (PE) ratio?

ATNFW's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is ATNFW's market capitalization?

ATNFW's market capitalization is $2,599,134.00, placing it in the small-cap tier.

ETHZilla Corporation Warrant (ATNFW)

Stock analysis · NASDAQ · Healthcare · Medical - Pharmaceuticals

$0.43

Market Cap

$2.60M

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.41

Day Range

$0.36 – $0.44

52-wk Range

$0.36 – $0.44

Avg Volume

N/A

Volume

1.62M

ETHZilla Corporation Warrant (ATNFW) is a publicly traded company in the Healthcare sector. Latest price: $0.43. Market cap $2.60M. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Mar 22, 2024

EPS $-2.29 vs est. $-22.80

Beat by $20.51

Proprietary Signals

Signal snapshot temporarily unavailable.

About ETHZilla Corporation Warrant

180 Life Sciences Corp. is a biotechnology firm currently in the clinical trial phase, dedicated to pioneering novel pharmaceutical treatments that address significant unmet medical needs in areas such as inflammatory conditions, fibrotic disorders, and pain management. This research and development effort is powered by the collective expertise of distinguished therapeutics specialists from Oxford University, the Hebrew University, and Stanford University. The company was co-founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016, and maintains its principal office in Palo Alto, California.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.00×
P/S (TTM)	0.00×
P/B	0.57×
P/FCF (TTM)	-0.00×
EV / EBITDA	0.00×
EV / Sales	-0.00×
Earnings Yield	-614023.01%
Free Cash Flow Yield	-974948.25%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	-$1.50M
Net Income (TTM)	-$15.96B
Free Cash Flow (TTM)	-$28.06B
Net Debt	-$4.10M
Working Capital	$8.91M
Gross Margin	0.02%
Operating Margin	-402.44%
Net Margin	-18427.17%
Return on Equity	-750.51%
Return on Invested Capital	-6350.01%